Clinical Germline Gene Editing Moratorium Letter

In a letter sent to U.S. Department of Health and Human Services Secretary Alex Azar on April 24, a broad collective of more than 60 scientists, bioethicists, and biotechnology executives across industry and academia called for collaboration on a binding global moratorium on human clinical germline experimentation until serious scientific, ethical, or societal concerns are addressed.

Read the Full Letter and
List of Signatories
(Updated April 24)

These initial signatories now invite their colleagues across the scientific, medical, patient, caregiver, policy, legal, ethical, and faith communities to signal their support for this initiative by signing on to their call to convene all these stakeholders.

First Name*
Last Name*
Are you a member of an ASGCT committee or leadership?:

e.g. Chair, Government Relations Committee

ASGCT Policy Summit
November 4 – 6 | Washington D.C.